Healthcare : India’s Changing Investment Landscape

India’s healthcare sector is entering a new phase of growth, with the industry expected to cross $610 billion by 2026. Rising incomes, broader insurance access, changing demographics, and the growing burden of lifestyle-related diseases are all contributing to this expansion. At the same time, healthcare remains highly local in delivery, and the quality of infrastructure as well as per capita spending continues to differ sharply across regions. For now, southern and western India remain ahead in terms of development and investment momentum.

The Rise of Senior Care
One of the most important long-term shifts shaping the sector is India’s ageing population. By 2036, senior citizens are expected to account for about 15% of the country’s population, with states such as Tamil Nadu and Kerala seeing a much higher concentration of elderly residents. This demographic transition is likely to create strong demand for age-friendly housing, assisted living, and organized eldercare services, with the need estimated to run into more than 2 million specialized units.

Despite that potential, senior care in India is still at an early stage. In more mature markets, categories such as assisted living, memory care, long-term care, and geriatric services are more clearly differentiated. In India, these services are still largely grouped together under the broad label of senior care. That creates both a challenge and an opportunity: the segment is poised for growth, but it will require sustained public and private investment to build capacity and avoid a larger social-care gap in the years ahead.

Nursing and Human Capital Challenges
The sector’s expansion will depend not only on physical infrastructure, but also on the availability of trained healthcare workers. India currently has about 1.7 nurses per 1,000 people, significantly below the WHO benchmark of 3 per 1,000. Although the country trains roughly 325,000 nurses each year, nearly half reportedly leave for international opportunities.

This imbalance is already placing pressure on providers. Staffing shortages, rising wages, and growing demand from hospitals and senior-care facilities are squeezing margins, especially for smaller hospitals in the 50-100 bed range. Without meaningful investment in workforce retention and training, human capital could become one of the biggest constraints on sector growth.

Insurance and FDI
Insurance penetration in India remains relatively low, but the direction of travel is positive. Government-backed schemes such as Ayushman Bharat (PM-JAY) have expanded access to healthcare for millions, with more than 45 crore beneficiaries covered and over 9.19 crore hospital admissions facilitated under the program.

With the insurance sector now open to 100% foreign direct investment, the industry could see a fresh wave of capital, innovation, and competition. Over time, that may accelerate product development, deepen penetration, and support broader access across the healthcare ecosystem.

Hospital Consolidation and Specialty Platforms
Consolidation is likely to remain a defining theme in the hospital sector. Multi-specialty hospital assets continue to attract strong investor interest, with valuations often ranging from the mid-teens to as high as 30x EBITDA. Large hospital groups are expanding into Tier 2 and Tier 3 markets through a mix of acquisitions and greenfield growth.

At the same time, these larger players may increasingly face competition from nimble, asset-light specialty platforms that focus on high-margin service lines. In that environment, the next stage of consolidation could involve leading multi-specialty operators acquiring specialty platforms or building out niche offerings in-house. The strategic goal will be clear: retain patients, improve profitability, and capture greater economies of scale.

Global Expansion and Medical Tourism
Indian healthcare providers are also beginning to look beyond domestic borders. Markets in the Middle East, Africa, and parts of Central Asia are becoming increasingly attractive, especially for well-capitalized hospital chains and specialty care platforms. Saudi Arabia, in particular, stands out as a promising destination for expansion because of its scale and margin potential.

This outward push may reduce some of the traditional gains from inbound medical tourism, but it also opens up new opportunities. Over the next five to seven years, outbound expansion could create attractive co-investment possibilities for Indian and Middle Eastern private equity investors seeking exposure to healthcare services.

Medical Devices and Import Substitution
Medical devices remain another major investment theme. India still imports 70-80% of its medical devices, even as the market is expected to reach $50 billion by 2030. That dependence on imports has created space for startups and domestic manufacturers focused on import substitution, supported in part by government incentives.

Even so, this opportunity comes with challenges. Indian device makers must still overcome concerns around credibility, consistency, and regulation, particularly as the domestic compliance environment continues to evolve. To compete internationally, companies will need globally recognized quality certifications and a strong execution track record.

An additional trend worth watching is overseas acquisition. Some ambitious Indian players, including well-funded pharmaceutical companies, are acquiring distressed medical device businesses in the U.S. and Europe to gain access to intellectual property, established approvals, and technical know-how, while relocating parts of the manufacturing base to India. Companies that combine this kind of strategic thinking with a sustained focus on quality could emerge as strong long-term bets for patient capital.

Diagnostics
Diagnostics is another segment drawing investor attention. The market is growing at an estimated 12% CAGR and is projected to reach $15-16 billion by FY30. One of the most visible shifts has been the growing popularity of home sample collection, particularly in crowded urban centers and among older patients, where convenience is a major differentiator.

The model is simple but powerful: high service levels, speed, and ease of access can materially improve the patient experience. As competition intensifies and margins come under pressure in the domestic market, some diagnostic providers may eventually look to international markets for the next leg of growth.

The Future: AI, Robotics, and Telemedicine
The next chapter in Indian healthcare will be shaped as much by technology as by capital. As consolidation increases, healthcare providers will have to rethink how they use technology at scale, including decisions around building systems internally versus acquiring them through partnerships or M\&A.

Artificial intelligence is likely to play a central role in that shift. Its most immediate value may come from improving productivity—whether in administrative workflows, clinical documentation, supply chain management, decision support, or claims processing. As larger hospital networks and insurers scale up, the need for interoperability, integration, and cost optimization will become even more important.

The opening of the insurance sector to 100% FDI could further accelerate digital adoption, especially in areas such as customer engagement, fraud detection, and claims management. Robotics also holds long-term promise, although adoption may be slowed by supply-chain constraints and intellectual-property concerns. Meanwhile, a more advanced version of telemedicine—one that is AI-enabled, integrated, and easier to use across fragmented systems—could create compelling opportunities for forward-looking investors.

About the Author
Dr. Saji Salam, MBBS, MBA, is a management consultant with extensive experience advising Fortune 500 healthcare organizations in the United States. He is also the founder of CareventuresCapital, a Houston-based private equity and advisory firm.